News
Investing.com -- OpenAI launched a new "study mode" feature in ChatGPT on Tuesday, designed to help users work through ...
Separately, Whirlpool proposed cutting its annual dividend to $3.60 from $7.00 and lowered its 2025 free cash flow guidance ...
Investing.com -- United Airlines flight attendants voted to reject a tentative agreement for a new contract with the carrier ...
The JPMorgan Equity Premium Income ETF has offered a 12-month trailing yield of 8.25%, while the JPMorgan Nasdaq Equity Premium Income ETF and the Global X Nasdaq 100 Covered Call ETF yielded 11.5% ...
Following its exciting unveiling at Annecy International Animation Festival last month, Marvel Animation’s “Eyes of Wakanda” ...
Investing.com -- Apple Inc (NASDAQ: AAPL ). has lost another key artificial intelligence researcher to Meta Platforms (NASDAQ ...
Investing.com -- U.S. Treasury Secretary Scott Bessent said Tuesday that President Donald Trump will make the final decision ...
The company reported that its second quarter total revenue is expected to exceed $365 million, surpassing its prior guidance of $345 million at the midpoint, and higher than analyst expectations of ...
Under the proposed deal, Northern Data would grant G42’s cloud-computing division, Core42, access to approximately half of its 23,000 Nvidia Corp . (NASDAQ: NVDA) graphics processing units (GPUs), ...
CyberArk Software (NASDAQ:CYBR) stock surged 15% Tuesday after the Wall Street Journal reported that Palo Alto Networks ...
Investing.com -- Anthropic is close to securing a new funding round of up to $5 billion that would value the artificial intelligence startup at $170 billion, according to Bloomberg.
Hims & Hers, which markets compounded versions of semaglutide through its telehealth platform, released clinical data shortly after Novo’s statement. The data showed that users of its compounded GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results